InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,618.26
(
-0.29%
)
US TECH 100
19,022.00
(
0.44%
)
Dow Jones
41,503.10
(
-0.25%
)
Brent Oil
73.18
(
1.11%
)
Bitcoin
61,937.81
(
0.43%
)
Post# of 13962
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Dcab

Send PM Follow Ignore
Followers 66
Posts 6963
Boards Moderated 0
Alias Born 10/06/2010

Dcab

Re: A deleted message

Tuesday, 04/13/2021 7:20:05 AM

Tuesday, April 13, 2021 7:20:05 AM

Post# of 13962
Here is what I found

In October 2019, Alexion entered into an asset purchase agreement with Immune Pharma to acquire an anti eotaxin-1 antibody for the development in inflammatory diseases. The agreement is pending completion due to bankruptcy proceedings, which are expected to conclude by the first quarter of 2020.

https://www.immunepharma.com/why-the-bertilimumab-bullous-pemphigoid-trial-is-so-important/

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up